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On behalf of the editorial board and staff, we proudly present Volume 5, Issue 2 of
the Health Lavi & Policy Brief. The tenth issue of our publication features the 2011
Health Law and Justice Initiative's symposium on personalized medicine, as well as
student articles addressing the topics of patent protection and information technology
in health care and medicine. Taken together, these pieces highlight the complex role
that scientific and technological advancement plays in society. Improvements in genetic
testing, information technology, pharmaceuticals, and medical devices create exciting
possibilities for persons and populations to attain the highest attainable standard of
health, but also raise grave and vexing questions regarding health inequity, regulation,
privacy, discrimination, ethics, and social justice.
The 2011 symposium delineates the legal, social, ethical, and political dimensions
of personalized medicine. Panel I focuses on the possibilities, hurdles, and practical
solutions of personalized medicine. By providing physicians and patients with treatment
options that are specifically tailored to individual patients, personalized medicine
may help patients achieve medically optimal outcomes. At the same time, however,
personalized medicine comes with challenges. For example, personalized medicine
may increase health inequities by offering new treatment options that may be affordable
only to a select few and remain inaccessible to a large segment of the population. Panel
II addresses ethical, budgetary, and privacy considerations. And Panel III focuses on
the import of consumer participation in advancing the goals of personalized medicine.
The student articles focus on patent law to explore further the challenges that accompany
innovations in medicine and health care. Tom Kniffen discusses how a recent federal
court decision and the Patient Protection and Affordable Care Act are likely to affect
patent protection of genetic research. Providing more of an international context, Kim
Speer examines the dual role that intellectual property protection plays in enabling
pharmaceutical innovation and ensuring access to drugs in developing countries.
Finally, several student authors report on new developments in information technology
in health care and medicine, and illuminate some of the ethical, regulatory, and privacy
considerations involved. Like the symposium on personalized medicine, this series of
short articles draws attention to the promise of technological and scientific innovation
in medicine and health care, but also highlights some of the obstacles to fulfilling that
promise.

Given the complex issues covered, we by no means present a definitive picture on any one of the topics presented, but rather
seek to promote further debate and inquiry into the topics discussed in this issue. The opinions expressed by the panelists at
the symposium and the student authors do not necessarily reflect the views of the Healthi

Law & Policy Briefor the American

University Washington College of Law.
We extend our gratitude to our faculty advisers, Professor Lindsay Wiley and Matthew Pierce, and our consulting advisor,
Professor Corrine Parver. Without their sage counsel and generous support, this publication would not be possible. We also
are enormously thankful to our dedicated, enthusiastic, and talented staff, who went above and beyond the call of duty to
deliver this issue of the Brief. We would also like to thank Justin Shore for organizing the Health Law and Justice Initiative's
symposium on personalized medicine and for his overall assistance, especially with helping the Brief obtain office space.
And finally, we thank you for your readership. We look forward to bringing you more health law and policy scholarship in
the future.
Sincerely,

Natassia Rozario

Laticia Sanchez

Kirsten Tullia

Editor-in-Chief
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Co-Executive Editor

